(1,3)-β-D-glucan-based diagnosis of invasive Candida infection versus culture-based diagnosis in patients with sepsis and with an increased risk of invasive Candida infection (CandiSep) study protocol for a randomized controlled trial

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Bloos, Frank (VerfasserIn), Held, Jürgen (VerfasserIn), Schlattmann, Peter (VerfasserIn), Brillinger, Nicole (VerfasserIn), Kurzai, Oliver (VerfasserIn), Cornely, Oliver A. (VerfasserIn), Thomas-Rüddel, Daniel (VerfasserIn)
Format: Elektronisch E-Book
Sprache:English
Veröffentlicht: Erlangen Friedrich-Alexander-Universität Erlangen-Nürnberg 2018
Schlagworte:
Online-Zugang:kostenfrei
kostenfrei
kostenfrei
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

MARC

LEADER 00000nmm a2200000zc 4500
001 BV045446299
003 DE-604
005 20190731
007 cr|uuu---uuuuu
008 190206s2018 gw |||| o||u| ||||||eng d
015 |a 18,O12  |2 dnb 
016 7 |a 1172503249  |2 DE-101 
024 7 |a urn:nbn:de:bvb:29-opus4-101506  |2 urn 
035 |a (OCoLC)1111842201 
035 |a (DE-599)DNB1172503249 
040 |a DE-604  |b ger  |e rda 
041 0 |a eng 
044 |a gw  |c XA-DE-BY 
049 |a DE-29 
084 |a 610  |2 sdnb 
100 1 |a Bloos, Frank  |e Verfasser  |4 aut 
245 1 0 |a (1,3)-β-D-glucan-based diagnosis of invasive Candida infection versus culture-based diagnosis in patients with sepsis and with an increased risk of invasive Candida infection (CandiSep)  |b study protocol for a randomized controlled trial  |c Frank Bloos, Jürgen Held, Peter Schlattmann, Nicole Brillinger, Oliver Kurzai, Oliver A. Cornely, Daniel Thomas-Rüddel 
264 1 |a Erlangen  |b Friedrich-Alexander-Universität Erlangen-Nürnberg  |c 2018 
300 |a 1 Online-Ressource 
336 |b txt  |2 rdacontent 
337 |b c  |2 rdamedia 
338 |b cr  |2 rdacarrier 
538 |a Langzeitarchivierung gewährleistet, LZA 
653 |a Sepsis 
653 |a Septic shock 
653 |a Invasive Candida infection 
653 |a Early antifungal therapy 
653 |a Biomarker 
700 1 |a Held, Jürgen  |e Verfasser  |4 aut 
700 1 |a Schlattmann, Peter  |e Verfasser  |4 aut 
700 1 |a Brillinger, Nicole  |e Verfasser  |4 aut 
700 1 |a Kurzai, Oliver  |e Verfasser  |4 aut 
700 1 |a Cornely, Oliver A.  |e Verfasser  |4 aut 
700 1 |a Thomas-Rüddel, Daniel  |e Verfasser  |4 aut 
787 0 8 |i Sonderdruck aus  |t Trials  |g Vol. 19 (2018)  |o 10.1186/s13063-018-2868-0 
856 4 0 |u http://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-101506  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u http://d-nb.info/1172503249/34  |x Langzeitarchivierung Nationalbibliothek  |z kostenfrei  |3 Volltext 
856 4 0 |u https://open.fau.de/handle/openfau/10150  |x Verlag  |z kostenfrei  |3 Volltext 
912 |a ebook 
999 |a oai:aleph.bib-bvb.de:BVB01-030831764 

Datensatz im Suchindex

_version_ 1804179339858673664
any_adam_object
author Bloos, Frank
Held, Jürgen
Schlattmann, Peter
Brillinger, Nicole
Kurzai, Oliver
Cornely, Oliver A.
Thomas-Rüddel, Daniel
author_facet Bloos, Frank
Held, Jürgen
Schlattmann, Peter
Brillinger, Nicole
Kurzai, Oliver
Cornely, Oliver A.
Thomas-Rüddel, Daniel
author_role aut
aut
aut
aut
aut
aut
aut
author_sort Bloos, Frank
author_variant f b fb
j h jh
p s ps
n b nb
o k ok
o a c oa oac
d t r dtr
building Verbundindex
bvnumber BV045446299
collection ebook
ctrlnum (OCoLC)1111842201
(DE-599)DNB1172503249
discipline Medizin
format Electronic
eBook
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02112nmm a2200505zc 4500</leader><controlfield tag="001">BV045446299</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20190731 </controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">190206s2018 gw |||| o||u| ||||||eng d</controlfield><datafield tag="015" ind1=" " ind2=" "><subfield code="a">18,O12</subfield><subfield code="2">dnb</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">1172503249</subfield><subfield code="2">DE-101</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">urn:nbn:de:bvb:29-opus4-101506</subfield><subfield code="2">urn</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1111842201</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DNB1172503249</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">gw</subfield><subfield code="c">XA-DE-BY</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-29</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">610</subfield><subfield code="2">sdnb</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Bloos, Frank</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">(1,3)-β-D-glucan-based diagnosis of invasive Candida infection versus culture-based diagnosis in patients with sepsis and with an increased risk of invasive Candida infection (CandiSep)</subfield><subfield code="b">study protocol for a randomized controlled trial</subfield><subfield code="c">Frank Bloos, Jürgen Held, Peter Schlattmann, Nicole Brillinger, Oliver Kurzai, Oliver A. Cornely, Daniel Thomas-Rüddel</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Erlangen</subfield><subfield code="b">Friedrich-Alexander-Universität Erlangen-Nürnberg</subfield><subfield code="c">2018</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="538" ind1=" " ind2=" "><subfield code="a">Langzeitarchivierung gewährleistet, LZA</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Sepsis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Septic shock</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Invasive Candida infection</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Early antifungal therapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Biomarker</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Held, Jürgen</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Schlattmann, Peter</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Brillinger, Nicole</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kurzai, Oliver</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cornely, Oliver A.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Thomas-Rüddel, Daniel</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="787" ind1="0" ind2="8"><subfield code="i">Sonderdruck aus</subfield><subfield code="t">Trials</subfield><subfield code="g">Vol. 19 (2018)</subfield><subfield code="o">10.1186/s13063-018-2868-0</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-101506</subfield><subfield code="x">Resolving-System</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://d-nb.info/1172503249/34</subfield><subfield code="x">Langzeitarchivierung Nationalbibliothek</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://open.fau.de/handle/openfau/10150</subfield><subfield code="x">Verlag</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ebook</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-030831764</subfield></datafield></record></collection>
id DE-604.BV045446299
illustrated Not Illustrated
indexdate 2024-07-10T08:18:18Z
institution BVB
language English
oai_aleph_id oai:aleph.bib-bvb.de:BVB01-030831764
oclc_num 1111842201
open_access_boolean 1
owner DE-29
owner_facet DE-29
physical 1 Online-Ressource
psigel ebook
publishDate 2018
publishDateSearch 2018
publishDateSort 2018
publisher Friedrich-Alexander-Universität Erlangen-Nürnberg
record_format marc
spelling Bloos, Frank Verfasser aut
(1,3)-β-D-glucan-based diagnosis of invasive Candida infection versus culture-based diagnosis in patients with sepsis and with an increased risk of invasive Candida infection (CandiSep) study protocol for a randomized controlled trial Frank Bloos, Jürgen Held, Peter Schlattmann, Nicole Brillinger, Oliver Kurzai, Oliver A. Cornely, Daniel Thomas-Rüddel
Erlangen Friedrich-Alexander-Universität Erlangen-Nürnberg 2018
1 Online-Ressource
txt rdacontent
c rdamedia
cr rdacarrier
Langzeitarchivierung gewährleistet, LZA
Sepsis
Septic shock
Invasive Candida infection
Early antifungal therapy
Biomarker
Held, Jürgen Verfasser aut
Schlattmann, Peter Verfasser aut
Brillinger, Nicole Verfasser aut
Kurzai, Oliver Verfasser aut
Cornely, Oliver A. Verfasser aut
Thomas-Rüddel, Daniel Verfasser aut
Sonderdruck aus Trials Vol. 19 (2018) 10.1186/s13063-018-2868-0
http://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-101506 Resolving-System kostenfrei Volltext
http://d-nb.info/1172503249/34 Langzeitarchivierung Nationalbibliothek kostenfrei Volltext
https://open.fau.de/handle/openfau/10150 Verlag kostenfrei Volltext
spellingShingle Bloos, Frank
Held, Jürgen
Schlattmann, Peter
Brillinger, Nicole
Kurzai, Oliver
Cornely, Oliver A.
Thomas-Rüddel, Daniel
(1,3)-β-D-glucan-based diagnosis of invasive Candida infection versus culture-based diagnosis in patients with sepsis and with an increased risk of invasive Candida infection (CandiSep) study protocol for a randomized controlled trial
title (1,3)-β-D-glucan-based diagnosis of invasive Candida infection versus culture-based diagnosis in patients with sepsis and with an increased risk of invasive Candida infection (CandiSep) study protocol for a randomized controlled trial
title_auth (1,3)-β-D-glucan-based diagnosis of invasive Candida infection versus culture-based diagnosis in patients with sepsis and with an increased risk of invasive Candida infection (CandiSep) study protocol for a randomized controlled trial
title_exact_search (1,3)-β-D-glucan-based diagnosis of invasive Candida infection versus culture-based diagnosis in patients with sepsis and with an increased risk of invasive Candida infection (CandiSep) study protocol for a randomized controlled trial
title_full (1,3)-β-D-glucan-based diagnosis of invasive Candida infection versus culture-based diagnosis in patients with sepsis and with an increased risk of invasive Candida infection (CandiSep) study protocol for a randomized controlled trial Frank Bloos, Jürgen Held, Peter Schlattmann, Nicole Brillinger, Oliver Kurzai, Oliver A. Cornely, Daniel Thomas-Rüddel
title_fullStr (1,3)-β-D-glucan-based diagnosis of invasive Candida infection versus culture-based diagnosis in patients with sepsis and with an increased risk of invasive Candida infection (CandiSep) study protocol for a randomized controlled trial Frank Bloos, Jürgen Held, Peter Schlattmann, Nicole Brillinger, Oliver Kurzai, Oliver A. Cornely, Daniel Thomas-Rüddel
title_full_unstemmed (1,3)-β-D-glucan-based diagnosis of invasive Candida infection versus culture-based diagnosis in patients with sepsis and with an increased risk of invasive Candida infection (CandiSep) study protocol for a randomized controlled trial Frank Bloos, Jürgen Held, Peter Schlattmann, Nicole Brillinger, Oliver Kurzai, Oliver A. Cornely, Daniel Thomas-Rüddel
title_short (1,3)-β-D-glucan-based diagnosis of invasive Candida infection versus culture-based diagnosis in patients with sepsis and with an increased risk of invasive Candida infection (CandiSep)
title_sort 1 3 β d glucan based diagnosis of invasive candida infection versus culture based diagnosis in patients with sepsis and with an increased risk of invasive candida infection candisep study protocol for a randomized controlled trial
title_sub study protocol for a randomized controlled trial
url http://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-101506
http://d-nb.info/1172503249/34
https://open.fau.de/handle/openfau/10150
work_keys_str_mv AT bloosfrank 13bdglucanbaseddiagnosisofinvasivecandidainfectionversusculturebaseddiagnosisinpatientswithsepsisandwithanincreasedriskofinvasivecandidainfectioncandisepstudyprotocolforarandomizedcontrolledtrial
AT heldjurgen 13bdglucanbaseddiagnosisofinvasivecandidainfectionversusculturebaseddiagnosisinpatientswithsepsisandwithanincreasedriskofinvasivecandidainfectioncandisepstudyprotocolforarandomizedcontrolledtrial
AT schlattmannpeter 13bdglucanbaseddiagnosisofinvasivecandidainfectionversusculturebaseddiagnosisinpatientswithsepsisandwithanincreasedriskofinvasivecandidainfectioncandisepstudyprotocolforarandomizedcontrolledtrial
AT brillingernicole 13bdglucanbaseddiagnosisofinvasivecandidainfectionversusculturebaseddiagnosisinpatientswithsepsisandwithanincreasedriskofinvasivecandidainfectioncandisepstudyprotocolforarandomizedcontrolledtrial
AT kurzaioliver 13bdglucanbaseddiagnosisofinvasivecandidainfectionversusculturebaseddiagnosisinpatientswithsepsisandwithanincreasedriskofinvasivecandidainfectioncandisepstudyprotocolforarandomizedcontrolledtrial
AT cornelyolivera 13bdglucanbaseddiagnosisofinvasivecandidainfectionversusculturebaseddiagnosisinpatientswithsepsisandwithanincreasedriskofinvasivecandidainfectioncandisepstudyprotocolforarandomizedcontrolledtrial
AT thomasruddeldaniel 13bdglucanbaseddiagnosisofinvasivecandidainfectionversusculturebaseddiagnosisinpatientswithsepsisandwithanincreasedriskofinvasivecandidainfectioncandisepstudyprotocolforarandomizedcontrolledtrial